Survival of AIDS‐related diffuse large B‐cell lymphoma, Burkitt lymphoma, and plasmablastic lymphoma in the German HIV Lymphoma Cohort

• DOI: 10.1111/bjh.13221
• Publication Date: 2014-11-18T04:17:49Z
• Authors: Philipp Schommers; Marcus Hentrich; Christian Hoffmann; Daniel Gillor; Alexander Zoufaly; Björn Jensen; Johannes R. Bogner; Jan Thoden; Jan‐Christian Was...; Timo Wolf; Mark Oette; Markus Müller; Stefan Esser; Jörg J. Vehreschild; Gerd Fätkenheuer; Christoph Wyen
• Keywords: Plasmablastic lymphoma; International Prognostic Index

Summary Overall survival ( OS ) of patients with acquired immunodeficiency syndrome AIDS )‐related Burkitt lymphoma BL ), diffuse large B‐cell DLBCL and plasmablastic PBL was analysed in the German ‐related‐Lymphoma‐Cohort‐Study. Of 291 prospectively included between January 2005 December 2012, 154 had , 103 34 . Two‐year rates were similar (69%) (63%) but lower for (43%). Intermediate (Hazard ratio [ HR ] 4·1 95% confidence interval CI 1·98–8·49) or high 4·92 2·1–11·61) International Prognostic Index, bone marrow involvement 1·69 1·00–2·84) histology 2·24 1·24–4·03) independent predictors mortality.